Reporting prostate cancer diagnostic imaging. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Neoplastic Cells, Circulating Stromal Cells Cell Nucleus

Organisms4

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C

Diseases35

Neoplasms Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Adenocarcinoma Disease Progression Neoplasm Metastasis Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Lung Neoplasms Carcinoma Neoplasm Recurrence, Local Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Pancreatic Neoplasms Prostatitis Urinary Bladder Neoplasms Neovascularization, Pathologic Colorectal Neoplasms Uterine Cervical Neoplasms Disease Models, Animal Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating Rectal Neoplasms Erectile Dysfunction Radiation Injuries Endometrial Neoplasms

Chemicals and Drugs69

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Tosyl Compounds Antineoplastic Agents Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists Anilides RNA, Messenger Dihydrotestosterone Finasteride Metribolone RNA, Small Interfering Flutamide Anticarcinogenic Agents Cancer Vaccines Glutamate Carboxypeptidase II Taxoids DNA, Neoplasm 5-alpha Reductase Inhibitors PTEN Phosphohydrolase Antigens, Neoplasm Testosterone Congeners Antineoplastic Agents, Phytogenic Testosterone Androstenols 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Azasteroids Nitriles Phenylthiohydantoin Proto-Oncogene Proteins c-akt RNA, Neoplasm Racemases and Epimerases MicroRNAs Tumor Suppressor Protein p53 Transcription Factors Cholestenone 5 alpha-Reductase Tumor Suppressor Proteins Estramustine Leuprolide Receptor, erbB-2 Goserelin Glutathione S-Transferase pi Antibodies, Monoclonal DNA-Binding Proteins Receptors, Estrogen DNA Primers Proto-Oncogene Proteins Enzyme Inhibitors Kallikreins Prostatic Secretory Proteins Proto-Oncogene Proteins c-bcl-2 Oncogene Proteins, Fusion Androgen-Binding Protein Steroid 17-alpha-Hydroxylase Radiopharmaceuticals Paclitaxel Biological Markers Insulin-Like Growth Factor Binding Protein 3 Ki-67 Antigen Reagent Kits, Diagnostic Carotenoids Receptor, Epidermal Growth Factor Nuclear Proteins Trans-Activators Cadherins

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Prostatectomy Orchiectomy Early Detection of Cancer Sensitivity and Specificity Neoplasm Staging Neoplasm Grading Prognosis Reverse Transcriptase Polymerase Chain Reaction Risk Factors Xenograft Model Antitumor Assays Digital Rectal Examination Prospective Studies Biopsy Retrospective Studies Neoplasm Transplantation Immunohistochemistry Case-Control Studies Transplantation, Heterologous Gene Expression Profiling Follow-Up Studies Blotting, Western Predictive Value of Tests Biopsy, Needle Risk Reproducibility of Results Transurethral Resection of Prostate Risk Assessment Survival Rate Survival Analysis Treatment Outcome Incidence Cohort Studies Odds Ratio Polymerase Chain Reaction Diagnostic Errors Diagnostic Imaging Oligonucleotide Array Sequence Analysis Brachytherapy Tumor Burden Transfection Tissue Array Analysis ROC Curve Combined Modality Therapy Multivariate Analysis Disease-Free Survival Registries Castration SEER Program Antineoplastic Combined Chemotherapy Protocols Logistic Models Diagnostic Tests, Routine Questionnaires Radiotherapy Mass Screening Kaplan-Meier Estimate Diagnostic Techniques and Procedures Molecular Targeted Therapy Nomograms Radiotherapy Dosage Drug Screening Assays, Antitumor Radiotherapy, Conformal Immunoenzyme Techniques Confidence Intervals Models, Biological Clinical Trials as Topic Tomography, X-Ray Computed Gene Knockdown Techniques Flow Cytometry Disease Models, Animal In Situ Hybridization, Fluorescence Enzyme-Linked Immunosorbent Assay Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Real-Time Polymerase Chain Reaction Magnetic Resonance Imaging Positron-Emission Tomography Chemotherapy, Adjuvant Reagent Kits, Diagnostic Immunotherapy Proportional Hazards Models Genetic Therapy Immunoblotting

Psychiatry and Psychology2

Smoking Erectile Dysfunction

Phenomena and Processes44

Gene Expression Regulation, Neoplastic Sensitivity and Specificity Cell Proliferation Genetic Predisposition to Disease Apoptosis Risk Signal Transduction Cell Growth Processes Drug Resistance, Neoplasm Genotype Down-Regulation Cell Division Cell Survival Odds Ratio Time Factors Cell Movement DNA Methylation Transfection Up-Regulation Promoter Regions, Genetic Mutation Polymorphism, Genetic Cell Cycle Dose-Response Relationship, Drug Nomograms Gene Silencing Gene Fusion Base Sequence Genes, Tumor Suppressor Chromosomes, Human, Pair 8 RNA Interference Gene Expression Polymorphism, Single Nucleotide Phosphorylation Diet Alleles Transcription, Genetic Phenotype Genes, Neoplasm Germ-Line Mutation Algorithms Drug Synergism Oncogene Fusion Radiation Tolerance

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence Radiotherapy, Conformal Molecular Sequence Data Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Algorithms

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care35

Patient Navigation Sensitivity and Specificity Risk Factors Prospective Studies Watchful Waiting Retrospective Studies Case-Control Studies Follow-Up Studies Predictive Value of Tests Risk Reproducibility of Results Risk Assessment Survival Rate Survival Analysis Treatment Outcome Incidence Cohort Studies Odds Ratio Diagnostic Errors Age Factors ROC Curve Multivariate Analysis Disease-Free Survival Registries SEER Program National Cancer Institute (U.S.)Logistic Models Questionnaires Mass Screening Kaplan-Meier Estimate Nomograms Confidence Intervals Clinical Trials as Topic Proportional Hazards Models Radiation Injuries

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Patient Navigation Prostate Neoplasms Prostatic Neoplasms Prostate-Specific Antigen Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Prostatectomy Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Orchiectomy Neoplasms, Hormone-Dependent Early Detection of Cancer Tumor Markers, Biological Adenocarcinoma Disease Progression Neoplasm Metastasis Mice, Nude Sensitivity and Specificity Prostatic Intraepithelial Neoplasia Tosyl Compounds Bone Neoplasms Neoplasm Invasiveness Neoplasm Staging Neoplasm Grading Prognosis Cell Proliferation Tumor Cells, Cultured Genetic Predisposition to Disease Antineoplastic Agents Antineoplastic Agents, Hormonal Reverse Transcriptase Polymerase Chain Reaction Apoptosis Risk Factors Neoplasm Proteins Androgen Receptor Antagonists Xenograft Model Antitumor Assays Digital Rectal Examination Anilides Breast Neoplasms Prospective Studies RNA, Messenger Watchful Waiting Biopsy Retrospective Studies Neoplasm Transplantation Immunohistochemistry Dihydrotestosterone Case-Control Studies Transplantation, Heterologous Finasteride Gene Expression Profiling Follow-Up Studies Lung Neoplasms Blotting, Western Predictive Value of Tests Carcinoma Biopsy, Needle Risk Reproducibility of Results Transurethral Resection of Prostate Metribolone Risk Assessment Neoplasm Recurrence, Local United States Signal Transduction Ovarian Neoplasms Cell Growth Processes Survival Rate Drug Resistance, Neoplasm Survival Analysis Prostatic Neoplasms, Castration-Resistant Genotype Treatment Outcome RNA, Small Interfering Flutamide Anticarcinogenic Agents Down-Regulation Cancer Vaccines Incidence Cohort Studies Glutamate Carboxypeptidase II Taxoids Cell Division Colonic Neoplasms Cell Survival Odds Ratio Polymerase Chain Reaction Mice, SCID Time Factors DNA, Neoplasm Diagnostic Errors 5-alpha Reductase Inhibitors Diagnostic Imaging Oligonucleotide Array Sequence Analysis PTEN Phosphohydrolase Stomach Neoplasms Brachytherapy

No FAQ available that match "reporting prostate cancer diagnostic imaging"